Albert Seymour, Chief Scientific Officer at Homology Medicines, Inc. (FIXX), sold 18,600 shares at $16.06 ($300K) on 2019-11-29, disclosed to the SEC on 2019-12-03.
Open-market sale of $300k FIXX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.06 | 9,300 | $149K | 49.7% |
| 2 | $16.23 | 9,300 | $151K | 50.3% |
| Total | $16.14 avg | 18,600 | $300K | 100% |
| Filing → |
| FIXX | SELL | 2022-01-12 | $6K | — | Filing → |
| FIXX | SELL | 2021-01-08 | $362K | — | Filing → |
| FIXX | SELL | 2021-01-07 | $114K | — | Filing → |